Tocilizumab (Actemra)
Revision as of 19:36, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "")
Mechanism of action
Monoclonal antibody directed against the IL-6 receptor
Diseases for which it is used
History of changes in FDA indication
- 1/8/2010: Initial FDA approval for rheumatoid arthritis
Also known as
- Brand name: Actemra